Beyond Skin Rejuvenation: Emerging Medical Applications of Red Light Therapy

Red Light Therapy Is More Than a Cosmetic Treatment

Red light therapy is widely recognized for its potential benefits in skin rejuvenation, collagen production, and improving the appearance of aging skin. However, scientific interest in this technology extends well beyond cosmetic applications. Researchers are investigating how specific wavelengths of red and near-infrared light may influence cellular activity, inflammatory processes, and tissue recovery.

Known scientifically as photobiomodulation (PBM), this noninvasive approach uses controlled light exposure to produce biological responses without intentionally heating or damaging tissue. Photobiomodulation can be delivered through specialized light-emitting diode (LED) devices or low-level therapeutic lasers. Although both technologies are used in research and clinical settings, their treatment characteristics and effectiveness depend on the equipment and protocols employed.

Emerging clinical research is exploring photobiomodulation for conditions such as tendinitis, peripheral neuropathy, chronic wounds, and certain inflammatory skin disorders. While some studies have reported encouraging results, the strength of evidence varies considerably among conditions. Understanding both the potential benefits and current scientific limitations is essential when evaluating red light therapy as a complementary therapeutic approach.

How Does Photobiomodulation Support Healing?

Red light LED photobiomodulation therapy device illuminated at Dr. Lea Kelley's wellness practice in Manhattan Beach, California

Professional red light LED photobiomodulation therapy device illuminated in Dr. Lea Kelley’s Manhattan Beach wellness practice.

Photobiomodulation (PBM) uses specific wavelengths of red and near-infrared light to influence biological processes at the cellular level. One proposed mechanism involves the absorption of light by mitochondrial components, particularly cytochrome c oxidase, an enzyme involved in cellular energy production. This interaction may influence adenosine triphosphate (ATP) production, helping regulate the energy available for normal cellular functions.

Researchers are also investigating how photobiomodulation affects nitric oxide signaling, oxidative stress, and inflammatory pathways. These biological responses may influence local circulation, cellular communication, and tissue repair processes. Laboratory and clinical studies suggest that the effects depend on several factors, including wavelength, light intensity, treatment duration, and the condition being investigated.

Although these mechanisms provide a scientific basis for exploring therapeutic applications, changes observed at the cellular level do not automatically translate into measurable clinical improvements. The effectiveness of photobiomodulation must be evaluated individually for each medical condition through appropriately designed clinical studies.

Red Light Therapy for Tendonitis and Bursitis

Tendinitis and bursitis are common causes of musculoskeletal pain, particularly around the shoulders, elbows, hips, and knees. Tendinitis involves irritation or inflammation of a tendon, while bursitis affects the small, fluid-filled sacs that cushion joints. Chronic tendon pain is often more accurately described as tendinopathy, which may involve degenerative changes rather than inflammation alone.

Researchers have investigated photobiomodulation as a potential complementary approach for managing tendon-related pain and supporting recovery. Clinical studies involving low-level laser therapy have reported improvements in pain associated with certain tendinopathies, including shoulder and lower-extremity conditions. Proposed mechanisms include changes in inflammatory signaling, cellular metabolism, and tissue repair processes.

However, research findings remain mixed, and treatment effectiveness depends on the condition, wavelength, dosage, and treatment protocol. Much of the available clinical evidence involves therapeutic lasers rather than LED panels. Evidence specifically supporting photobiomodulation for bursitis is more limited. Red light therapy should therefore be considered a potential complementary intervention rather than a replacement for appropriate diagnosis, rehabilitation exercises, or other established treatments.

Photobiomodulation for Peripheral Neuropathy

Peripheral neuropathy occurs when nerves outside the brain and spinal cord become damaged or dysfunctional. Common symptoms include burning sensations, tingling, numbness, pain, and changes in sensitivity, particularly in the hands and feet. Diabetes is a leading cause, although neuropathy may also develop from nutritional deficiencies, certain medications, chemotherapy, autoimmune conditions, and other underlying health problems.

Researchers are investigating photobiomodulation as a potential complementary approach for managing neuropathic pain and supporting nerve function. Clinical studies involving diabetic peripheral neuropathy have reported improvements in pain intensity, sensory symptoms, and certain measures of nerve function. Proposed mechanisms include modulation of inflammatory pathways, mitochondrial activity, and cellular processes involved in nerve health.

Although these findings are promising, the available research remains limited by differences in treatment protocols, device specifications, and study quality. Most clinical investigations have involved specific therapeutic laser or infrared light systems, and their results cannot automatically be generalized to all LED devices. Photobiomodulation is not an established treatment for reversing peripheral nerve damage and should not replace evaluation and management of the underlying cause.

Red Light Therapy for Chronic Wounds and Tissue Repair

Chronic wounds are injuries that fail to progress through the normal stages of healing. They may develop in individuals with diabetes, impaired circulation, prolonged pressure, or other conditions that interfere with tissue repair. Diabetic foot ulcers are a particular concern because delayed healing can increase the risk of infection and other serious complications.

Researchers are investigating photobiomodulation as a potential complementary approach to wound healing. Laboratory and clinical studies suggest that specific wavelengths of red and near-infrared light may influence cellular metabolism, inflammatory signaling, microcirculation, and processes involved in tissue regeneration. Some clinical trials involving diabetic foot ulcers have reported improvements in wound size and healing outcomes when light-based therapies were added to conventional wound care.

However, clinical findings vary considerably depending on the wound type, treatment parameters, and device technology. Research involving therapeutic lasers cannot automatically be applied to LED devices, and the overall certainty of evidence remains limited. Photobiomodulation is not a replacement for established wound management, including infection control, circulation assessment, pressure relief, and appropriate medical supervision. Chronic or nonhealing wounds require professional evaluation before considering additional therapies.

Red Light Therapy for Psoriasis and Eczema

Psoriasis and eczema (atopic dermatitis) are chronic inflammatory skin conditions that can cause redness, itching, irritation, and discomfort. Psoriasis is an immune-mediated condition associated with accelerated skin cell turnover, while eczema involves inflammation and disruption of the skin’s protective barrier. Although their underlying mechanisms differ, both conditions can significantly affect skin health and quality of life.

Researchers have investigated whether photobiomodulation and other visible-light therapies may help influence inflammatory processes associated with these conditions. Small clinical studies involving specific LED wavelengths have reported improvements in certain symptoms of psoriasis and eczema. However, much of this research has involved blue light rather than red or near-infrared light, and the available evidence is insufficient to establish red light therapy as an effective treatment for either condition.

It is important to distinguish red light therapy from ultraviolet (UV) phototherapy. Narrowband UVB is an established dermatological treatment for psoriasis and is also used for selected patients with eczema. Unlike UV phototherapy, red and near-infrared photobiomodulation does not rely on ultraviolet radiation. Although these approaches use light to influence biological processes, they are not interchangeable. Patients with psoriasis or eczema should seek appropriate dermatological evaluation and continue recommended treatments rather than relying on red light therapy alone.

Why Wavelength, Dosage, and Device Quality Matter

Not all red light therapy devices deliver the same wavelengths, intensity, or therapeutic dose. These differences are important because the biological effects of photobiomodulation depend on how light interacts with specific tissues. Understanding device specifications helps explain why results from one clinical study cannot automatically be applied to every red light therapy product.

Red light versus near-infrared light: Red wavelengths, commonly around 630–660 nanometers (nm), are frequently investigated for superficial tissues such as the skin. Near-infrared wavelengths, often around 810–850 nm, generally penetrate farther into biological tissues and are commonly studied for musculoskeletal and other applications involving deeper structures. However, penetration and biological effects also depend on tissue characteristics and treatment parameters.

Dosage and treatment frequency: Photobiomodulation follows a complex dose-response relationship. Researchers have observed that insufficient light exposure may produce little measurable effect, while excessive exposure may reduce or inhibit certain beneficial biological responses. Treatment outcomes depend on irradiance (light intensity), energy density, exposure time, treatment frequency, and the condition being addressed. Longer or more frequent treatments are not necessarily more effective.

LED devices versus therapeutic lasers: Both light-emitting diodes (LEDs) and low-level therapeutic lasers can deliver wavelengths used in photobiomodulation. Although lasers produce more concentrated and directional light, LEDs can also produce biological effects when appropriate treatment parameters are used. Device quality, accurate wavelength specifications, consistent light output, and appropriate treatment protocols are more meaningful considerations than simply whether a device uses LEDs or lasers. Consumers should be cautious about assuming that inexpensive home devices reproduce the treatment conditions or clinical outcomes reported in published research.

What Does the Current Scientific Evidence Tell Us?

Scientific research on photobiomodulation has expanded considerably, with clinical trials and systematic reviews investigating its potential applications across numerous health conditions. Some studies have reported improvements in pain, physical function, tissue healing, and other clinical outcomes. However, the strength of evidence varies substantially depending on the condition being treated and the specific outcomes measured.

A 2025 umbrella review examining 204 randomized controlled trials involving more than 9,000 participants found promising therapeutic effects for several conditions. Moderate-certainty evidence supported selected outcomes involving knee osteoarthritis, fibromyalgia, androgenetic alopecia, and other conditions. However, no evaluated outcome was supported by high-certainty evidence, and many findings remained limited by differences in study design, sample size, and treatment protocols.

These findings highlight both the potential and the limitations of photobiomodulation. While certain applications have encouraging clinical support, others—including some uses for peripheral neuropathy, chronic wounds, and inflammatory skin conditions—require additional investigation. Larger, well-controlled clinical trials using standardized treatment parameters are needed to clarify which patients may benefit, what treatment protocols are most effective, and whether improvements can be sustained over time.


Exploring Red Light Therapy in Manhattan Beach

Red light therapy is one of the complementary technologies offered by Dr. Lea Kelley at The Dragon and Phoenix Healer in Manhattan Beach, California. With 30 years of experience in acupuncture, chiropractic care, and holistic healthcare, Dr. Kelley incorporates LED light therapy into her integrative approach to patient wellness.

While research continues to explore additional medical applications of photobiomodulation, treatment decisions should be based on individual health needs, available clinical evidence, and appropriate device specifications. Not every condition discussed in this article represents an established indication for red light therapy.

Learn more about Red Light Therapy in Manhattan Beach

Interested in Red Light Therapy?

Discover how red light and LED therapy may complement your individualized wellness care at The Dragon and Phoenix Healer in Manhattan Beach.

Clinical Research and References

The following peer-reviewed publications provide additional information about the potential therapeutic applications of photobiomodulation (PBM), including its clinical outcomes, treatment parameters, and current scientific limitations.

1. Photobiomodulation Across Multiple Health Conditions (2025)
Effects of Photobiomodulation on Multiple Health Outcomes: An Umbrella Review of Randomized Clinical Trials.
Systematic Reviews.
https://doi.org/10.1186/s13643-025-02902-3

2. Photobiomodulation Treatment Parameters (2021)
Review of Light Parameters and Photobiomodulation Efficacy: Dive Into Complexity.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8355782/

3. Peripheral Neuropathy (2025)
A Single-Blinded Randomized Controlled Trial Assessing the Effect of Photobiomodulation Therapy on Neuron-Specific Biomarkers in Type II Diabetes Mellitus Patients With Peripheral Neuropathy.
https://pubmed.ncbi.nlm.nih.gov/40090424/

4. Diabetic Peripheral Neuropathy — Systematic Review (2023)
Effectiveness of Photobiomodulation Therapy on Neuropathic Pain, Nerve Conduction and Plantar Pressure Distribution in Diabetic Peripheral Neuropathy.
https://pubmed.ncbi.nlm.nih.gov/37622461/

5. Diabetic Foot Ulcers — Systematic Review and Meta-Analysis (2024)
Efficacy and Safety of Red and Infrared Light in the Adjunctive Treatment on Diabetic Foot Ulcers.
https://pubmed.ncbi.nlm.nih.gov/39305794/

6. LED Therapy in Dermatology (2018)
Light-Emitting Diodes in Dermatology: A Systematic Review of Randomized Controlled Trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6099480/

7. Phototherapy for Psoriasis and Atopic Dermatitis (2019)
Advances in Phototherapy for Psoriasis and Atopic Dermatitis.
https://pubmed.ncbi.nlm.nih.gov/31575297/

Next
Next

Why You Can Feel Exhausted Despite Normal Lab Results